1. Home
  2. OBIO vs NEWT Comparison

OBIO vs NEWT Comparison

Compare OBIO & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

SELL

Current Price

$5.64

Market Cap

362.4M

Sector

Health Care

ML Signal

SELL

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

SELL

Current Price

$10.57

Market Cap

400.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
OBIO
NEWT
Founded
2017
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
362.4M
400.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
OBIO
NEWT
Price
$5.64
$10.57
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$12.43
★ $15.40
AVG Volume (30 Days)
★ 291.4K
220.4K
Earning Date
11-09-2026
10-28-2026
Dividend Yield
N/A
★ 6.93%
EPS Growth
★ 33.13
11.22
EPS
N/A
★ 0.90
Revenue
★ $33,482,000.00
N/A
Revenue This Year
N/A
$5.48
Revenue Next Year
$33.03
$9.84
P/E Ratio
★ N/A
$12.18
Revenue Growth
★ 1169.22
N/A
52 Week Low
$3.26
$9.59
52 Week High
$6.50
$15.69

Technical Indicators

Market Signals
Indicator
OBIO
NEWT
Relative Strength Index (RSI) 46.61 25.36
Support Level $3.67 $10.40
Resistance Level $5.78 $11.57
Average True Range (ATR) 0.32 0.25
MACD -0.08 0.01
Stochastic Oscillator 20.72 2.48

Price Performance

Historical Comparison
OBIO
NEWT

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

About NEWT NewtekOne Inc.

NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.

Share on Social Networks: